Nevertheless, across 19 cases of AD having different genetic risk profiles, we found an association of TMCC2 immunoreactivity with the pathology of AD, suggesting novel directions for investigation into the mechanisms by which TMCC2 and apoE may contribute to AD pathogenesis. Here, APOE is linked to Alzheimer disease.